|
VeriChip Corporation Announces Sales of VeriTrace
System to Two New Jersey Counties
DELRAY BEACH, FL –
April 20, 2009 --
VeriChip Corporation (NASDAQ:CHIP) (“VeriChip”), a provider of radio
frequency identification (RFID) systems for healthcare and
patient-related needs, announced today that
it has sold the VeriTrace™ system for disaster relief and emergency
management needs to Atlantic and Mercer counties in New Jersey.
Marc Poulshock, Vice President of VeriChip’s
Implantable and Emergency Management divisions, said, “These recent
orders reflect the continued demand for the VeriTrace system by
emergency management personnel and medical examiners throughout the
country. Since the federal government continues to support the
necessity to be prepared for potential natural catastrophes or acts
of terrorism, we will maintain our ongoing discussions with these
organizations in the
U.S. and internationally.”
The VeriTrace system was created in the aftermath of
Hurricane Katrina where it proved helpful in identifying, tracking
and accounting for the remains of victims from the hurricane.
VeriTrace was used by the Federal Disaster
Mortuary Operational Response Team (DMORT) during Hurricane Katrina
recovery operations.
VeriTrace is designed to assist state and federal
agencies in the management of emergency situations and disaster
recovery using implantable RFID technology. The VeriTrace system
includes a unique implantable RFID microchip, a VeriTrace
Bluetooth(TM) handheld reader, a customized Ricoh 500SE Digital
Camera capable of receiving both RFID scanned data and GPS data
wirelessly, and a Web-enabled database for gathering and storing
information and images captured during emergency response
operations. This database ensures the precise collection, storage
and inventory of all data and images related to remains and the
associated evidentiary items. This also allows the recreation of an
accurate and complete reconstruction of a disaster setting, crime
scene or similar setting where recreation is necessary.
About VeriChip Corporation
VeriChip Corporation,
headquartered in Delray
Beach, Florida,
has developed the VeriMed™ Health Link System for rapidly and
accurately identifying people who arrive in an emergency room and
are unable to communicate. This system uses the first
human-implantable passive RFID microchip, cleared for medical use in
October 2004 by the United States Food and Drug Administration. To
complement its healthcare division, VeriChip Corporation established
VeriGreen Energy Corporation in March 2009 to focus and invest in
the clean and alternative energy sector.
For
more information on VeriChip, please call 1-800-970-2447, or e-mail
info@verichipcorp.com. Additional information can be found online at
www.verichipcorp.com.
Statements about VeriChip’s future expectations,
including future revenues and earnings from the sale of VeriTrace,
and all other statements in this press release other than historical
facts are “forward-looking statements” within the meaning of Section
27A of the Securities Act of 1933, Section 21E of the Securities
Exchange Act of 1934, and as that term is defined in the Private
Litigation Reform Act of 1995. Such forward-looking statements
involve risks and uncertainties and are subject to change at any
time, and VeriChip’s actual results could differ materially from
expected results. Additional information about these and other
factors that could affect the Company’s business is set forth in the
Company’s various filings with the Securities and Exchange
Commission, including those set forth in the Company’s 10-K filed on
February 12, 2009, under the caption “Risk Factors.” The Company
undertakes no obligation to update or release any revisions to these
forward-looking statements to reflect events or circumstances after
the date of this statement or to reflect the occurrence of
unanticipated events, except as required by law.
###
CONTACT:
VeriChip
Corporation
Allison Tomek
(561) 805-8008
atomek@verichipcorp.com
Back
|
